SciMatic Home SciMatic
  • Journals
  • Thesis Rep
  • Docs
  • Products
    SciMatic.net Journament Journal Manager Subjects Thesis ImProofer Research Groups Letter Pad Conferences
  • Services
  • About
    SciMatic Blog Team Earn With Us Join Us Contact Us
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文
Login

Keyword Connections

cetuximab
Journals
3
1 Frontiers in oncology
2 cancer
3 drug delivery and translational research
Research Groups
0
No Research Group Connected
Bibliographies
7
1 Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy.
2 A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
3 Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
4 a pilot study (swog s0429) of weekly cetuximab and chest radiotherapy for poor-risk stage iii non-small cell lung cancer
5 identification and characterization of egf receptor in individual exosomes by fluorescence-activated vesicle sorting
6 anti pd-l1 durvalumab combined with cetuximab and radiotherapy in locally advanced squamous cell carcinoma of the head and neck: a phase i/ii study (ducro)
7 A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.
SciMatic
SciMatic on Your Phone Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play
About
  • About
  • Team
  • Join Us
  • Privacy and Security
  • KVKK Aydınlatma Metni
  • Cookie settings
  • Terms of Sale
  • Publication Terms
  • Blacklisted Persons
  • Delete Account
  • Documentations
Services
  • Thesis Manager
  • Semester Manager
  • Journals
  • Conferences
  • Journament Indexings
  • API
Legal
SciMatic © 2014–2026 ZincirX Inc.

All Rights Reserved!

Creative Commons License
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SciBot
AI Assistant
Hi! I'm SciBot, your SciMatic assistant. I can help with manuscript submissions, journal info, and navigating the platform. How can I help?

How we process your personal data: Privacy Notice. In Türkiye: KVKK Aydınlatma Metni.

Contact Us
Login Required

Register/Login first to send a message

Login

Cookies

We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use analytics (Google Analytics, Google Tag Manager, Yandex Metrica) to see how the site is used, Google AdSense to show ads, and the Meta Pixel to measure our own ads on Facebook and Instagram. They stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)

Cookie settings

Your session, form security (XSRF) and this choice. The site does not work without them.
Google Analytics 4 and Google Tag Manager (Google LLC, USA; the _ga and _ga_* cookies, up to 2 years) and, on some pages, Yandex Metrica (Yandex LLC, Russia; _ym_uid and _ym_d up to 1 year, and other _ym cookies): measure which pages are visited and what is clicked.
Google AdSense (Google LLC, USA): shows and measures ads; the __gads, __gpi and __eoi cookies are kept for up to 13 months, and Google may also use ad cookies on its own domains.
Meta Pixel and Conversions API (Meta Platforms Ireland Ltd. and Meta Platforms, Inc., USA): measure whether our ads on Facebook and Instagram lead to sign-ups and purchases, and improve them. The _fbp and _fbc cookies are kept for up to 90 days; when you sign up, start a checkout or buy, our server also tells Meta, with a hashed (SHA-256) e-mail address.